Avera Cancer Institute at Yankton is a clinical research site located in Yankton, South Dakota, United States 57078.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Avera Cancer Institute at Yankton has participated in 20 clinical trials with 20 currently active.
Therapeutic areas: Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma.
Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), NRG Oncology.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Avera Cancer Institute at Yankton has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Avera Cancer Institute at Yankton has 20 clinical trials on record, with 20 currently active. Their work covers Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma.
Yes — Avera Cancer Institute at Yankton holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.